Science Corporation has announced the acquisition of intellectual property and related assets for the Prima retinal implant from French bioelectronics company Pixium Vision. Financial terms of the deal were undisclosed. The Prima system complements Science Corporation’s Science Eye product, which targets blindness caused by retinitis pigmentosa and dry age-related macular degeneration.